Anti-inflammatory and barrier protecting effect of Lithospermum erythrorhizon extracts in chronic oxazolone-induced murine atopic dermatitis.
Lee
Ji Hae
JH
Jung
Kyoung-Mi
KM
Bae
Il-Hong
IH
Cho
SiYoung
S
Seo
Dae-Bang
DB
Lee
Sang-Jun
SJ
Park
Young-Ho
YH
Lim
Kyung-Min
KM
D000284:Administration, Oral; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002908:Chronic Disease; D051546:Cyclooxygenase 2 / Q000187:drug effects / Q000378:metabolism; D003876:Dermatitis, Atopic / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D020672:I-kappa B Proteins / Q000187:drug effects / Q000378:metabolism; D029684:Lithospermum / Q000737:chemistry*; D051379:Mice; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B / Q000819:agonists / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II / Q000187:drug effects / Q000378:metabolism; D010081:Oxazolone / Q000494:pharmacology; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects / Q000473:pathology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D020672:I-kappa B Proteins; D016328:NF-kappa B; C000606205:Nfkbia protein, mouse; D010936:Plant Extracts; D000072000:NF-KappaB Inhibitor alpha; D010081:Oxazolone; D011239:Prednisolone; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse; C077623:Ptgs2 protein, mouse; D051546:Cyclooxygenase 2